Chief Financial Officer · Indivior Pharmaceuticals, Inc. · Common Stock
Side
SELL
Value
$1.36M
Shares
36.0K
Price
$37.7
Executed
Jun 8, 2026
Disclosed
Jun 10, 2026
Disclosure timeline2 days from execution to publication · legal deadline 2 business days
Jun 8 executedJun 10, 2026 disclosed
INDV · daily
Yahoo Finance chart API
▲Execution▼Disclosure●Material company filing●Other disclosed buy●Other disclosed sellUnofficial public endpoint; daily OHLCV, split-adjusted. Replace with a licensed feed for production.
Disclosed 2 business days after execution (deadline: 2)
Historical behavior+8 / 15
First recorded trade by this actor in this security
Frequency & clustering+5 / 15
1 other actor traded the same direction within 14 days
Market events0 / 10
No material company filing within 60 days after the trade
Pre-arranged plan-10
Executed under a Rule 10b5-1 trading plan
The Insider Score measures how far a disclosure deviates from normal filing patterns. A high score is a prompt for research, not evidence of illegal insider trading.
Preblick Ryan filed this Form 4 reporting a open-market sale of INDV on Jun 8, 2026. It became public on Jun 10, 2026. The filing establishes the reported transaction and the filer's stated role. It does not establish why the trade was made or what the filer knew.
Extraction
Method
Form 4 XML
Confidence
1.00
Chief Financial Officer
Preblick Ryancik:0002014866
Issuer
Indivior Pharmaceuticals, Inc.cik:0001625297
Revision history · 0
No field has changed since this record was first ingested.
